Cargando…
Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach
Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Gastrointestinal Intervention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187815/ https://www.ncbi.nlm.nih.gov/pubmed/30309202 http://dx.doi.org/10.5808/GI.2018.16.3.44 |
_version_ | 1783363092413939712 |
---|---|
author | Sood, Damini Kumar, Neeraj Singh, Aarushi Sakharkar, Meena Kishore Tomar, Vartika Chandra, Ramesh |
author_facet | Sood, Damini Kumar, Neeraj Singh, Aarushi Sakharkar, Meena Kishore Tomar, Vartika Chandra, Ramesh |
author_sort | Sood, Damini |
collection | PubMed |
description | Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character. |
format | Online Article Text |
id | pubmed-6187815 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Society of Gastrointestinal Intervention |
record_format | MEDLINE/PubMed |
spelling | pubmed-61878152018-10-17 Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach Sood, Damini Kumar, Neeraj Singh, Aarushi Sakharkar, Meena Kishore Tomar, Vartika Chandra, Ramesh Genomics Inform Original Article Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character. Society of Gastrointestinal Intervention 2018-09 2018-09-30 /pmc/articles/PMC6187815/ /pubmed/30309202 http://dx.doi.org/10.5808/GI.2018.16.3.44 Text en Copyright © 2018 by the Korea Genome Organization It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/). |
spellingShingle | Original Article Sood, Damini Kumar, Neeraj Singh, Aarushi Sakharkar, Meena Kishore Tomar, Vartika Chandra, Ramesh Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title | Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title_full | Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title_fullStr | Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title_full_unstemmed | Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title_short | Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach |
title_sort | antibacterial and pharmacological evaluation of fluoroquinolones: a chemoinformatics approach |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6187815/ https://www.ncbi.nlm.nih.gov/pubmed/30309202 http://dx.doi.org/10.5808/GI.2018.16.3.44 |
work_keys_str_mv | AT sooddamini antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach AT kumarneeraj antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach AT singhaarushi antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach AT sakharkarmeenakishore antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach AT tomarvartika antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach AT chandraramesh antibacterialandpharmacologicalevaluationoffluoroquinolonesachemoinformaticsapproach |